Bombesin inhibits alveolarization and promotes pulmonary fibrosis in newborn mice

American Journal of Respiratory and Critical Care Medicine

Volumn 173, Issue 12, 2006, Pages 1377-1385

  Ashour, Khalid ^b   Shan, Lin ^b   Jong, Hwan Lee ^b   Schlicher, William ^b   Wada, Keiji ^b   Wada, Etsuko ^b   Sunday, Mary E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Bronchopulmonary dysplasia; Gastrin releasing peptide; Interstitial fibrosis; Knock out mice

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BOMBESIN; BOMBESIN RECEPTOR; GASTRIN RELEASING PEPTIDE; GASTRIN RELEASING PEPTIDE RECEPTOR; NEUROMEDIN B; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS; LUNG ALVEOLUS WALL; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG FIBROSIS; LUNG INFLATION; MEDICAL RESEARCH; MOUSE; MYOFIBROBLAST; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL;

ACTINS; ANIMALS; ANIMALS, NEWBORN; BOMBESIN; CELL PROLIFERATION; FIBROBLASTS; GASTRIN-RELEASING PEPTIDE; GASTROINTESTINAL AGENTS; INJECTIONS, INTRAPERITONEAL; LIGANDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROKININ B; NEUROTRANSMITTER AGENTS; PROLIFERATING CELL NUCLEAR ANTIGEN; PULMONARY ALVEOLI; PULMONARY FIBROSIS; RECEPTORS, BOMBESIN;

EID: 33745128353     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.200507-1014OC     Document Type: Article

References (45)

1. Sunday ME, Wolfe HJ, Roos BA, Chin WW, Spindel ER. Gastrinreleasing peptide gene expression in developing, hyperplastic, and neoplastic human thyroidal C-cells. Endocrinology 1988;122:1551-1558.
2. Sunday ME. Neuropeptides and lung development. In: McDonald JA, editor. Lung growth and development, 1st ed. New York: Marcel Dekker; 1997. pp. 401-494.
3. Erspamer V. Amphibian skin peptides in mammals: looking ahead. Trends Neurosci 1983;6:200-201.
4. McDonald TJ, Jornvall H, Nilsson G, Vagne M, Ghatei M, Bloom SR, Mutt V. Characterization of a gastrin-releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun 1979;90:227-233.
5. Wharton J, Polak JM, Bloom SR, Ghatei MA, Solcia E, Brown MR, Pearse AGE. Bombesin-like immunoreactivity in the lung. Nature 1978;273:769-770.
6. Cutz E. Cytomorphology and differentiation of airway epithelium in developing human lung. In: McDowell EM, editor. Lung carcinomas: current problems in tumor pathology, Edinburgh: Churchill Livingstone; 1987. pp. 1-41.
7. Ten Have-Opbroek AAW. Lung development in the mouse embryo. Exp Lung Res 1991;17:111-130.
8. Sunday ME, Hua J, Dai HB, Nusrat A, Torday JS. Bombesin increases fetal lung growth and maturation in utero and in organ culture. Am J Respir Cell Mol Biol 1990;3:199-205.
9. Sunday ME, Hua J, Reyes B, Masui H, Torday JS. Anti-bombesin antibodies modulate fetal mouse lung growth and maturation in utero and in organ cultures. Anat Rec 1993;236:25-32.
10. Sunday ME, Hua J, Torday J, Reyes B, Shipp MA. CD10/neutral endopeptidase 24.11 in developing human fetal lung: patterns of expression and modulation of peptide-mediated proliferation. J Clin Invest 1992;90:2517-2525.
11. King KA, Torday JS, Sunday ME. Bombesin and [leu8]phyllolitorin promote fetal mouse lung branching morphogenesis via a specific receptor-mediated mechanism. Proc Natl Acad Sci USA 1995;92:4357-4361.
12. Northway WH. Bronchopulmonary dysplasia: twenty-five years later. Pediatrics 1992;89:969-973.
13. Abman SH, Groothius JR. Pathophysiology and treatment of bronchopulmonary dysplasia: current issues. Pediatr Clin North Am 1994;41:277-315.
14. Johnson DE, Lock JE, Elde RP, Thompson TR. Pulmonary neuroendocrine cells in hyaline membrane disease and bronchopulmonary dysplasia. Pediatr Res 1982;16:446-454.
15. Cullen A, Van Marter LJ, Moore M, Parad R, Sunday ME. Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia. Am J Respir Crit Care Med 2002;165:1093-1097.
16. Sunday ME, Yoder BA, Cuttitta F, Haley KJ, Emanuel RL. Bombesinlike peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia. J Clin Invest 1998;102:584-594.
17. Impicciatore M, Bertaccini G. The bronchoconstrictor action of the tetradecapeptide bombesin in the guinea-pig. J Pharm Pharmacol 1973;25:872-875.
18. Ganter MT, Pittet JF. Bombesin-like peptides: modulators of inflammation in acute lung injury? Am J Respir Crit Care Med 2006;173:1-2.
19. Ohki-Hamazaki H, Wada E, Matsui K, Wada K. Cloning and expression of the neuromedin B receptor and the third subtype of bombesin receptor genes in the mouse. Brain Res 1997;762:165-172.
20. Wada E, Watase K, Yamada K, Ogura H, Yamano M, Inomata Y, Eguchi J, Yamamoto K, Sunday ME, Maeno H, et al. Generation and characterization of mice lacking gastrin-releasing peptide receptor. Biochem Biophys Res Commun 1997;239:28-33.
21. Ohki-Hamazaki H, Sakai Y, Kamata K, Ogura H, Okuyama S, Watase K, Yamada K, Wada K. Functional properties of two bombesin-like peptide receptors revealed by the analysis of mice lacking neuromedin B receptor. J Neurosci 1999;19:948-954.
22. Ohki-Hamazaki H, Watase K, Yamamoto K, Ogura H, Yamano M, Yamada K, Maeno H, Imaki J, Kikujama S, Wada E, et al. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature 1997;390:165-169.
23. Lin JT, Coy DH, Mantey SA, Jensen RT. Comparison of the peptide structural requirements for high affinity interaction with bombesin receptors. Eur J Pharmacol 1995;294:55-69.
24. Benya RV, Kusui T, Pradhan TK, Battey JF, Jensen RT. Expression and characterization of cloned human bombesin receptors. Mol Pharmacol 1995;47:10-20.
25. Lach E, Haddad EB, Gies JP. Contractile effect of bombesin on guinea pig lung in vitro: involvement of gastrin-releasing peptide-preferring receptors. Am J Physiol 1993;264:L80-L86.
26. Mantey SA, Coy DH, Entsuah LK, Jensen RT.Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3. J Pharmacol Exp Ther 2004;310:1161-1170. Epub 2004 Apr 21.
27. Sunday ME, Shan L, Subramaniam M. Immunomodulatory functions of the diffuse neuroendocrine system: implications for bronchopulmonary dysplasia. Endocr Pathol 2004;15:91-106.
28. Ashour KMN, Sunday ME. Bombesin given perinatally diminished alveolar development in mice [abstract]. Pediatr Res 2002;51:61A(abstract 353).
29. Pua ZJ, Stonestreet BS, Cullen A, Shahsafaei A, Sadowska GB, Sunday ME. Histochemical analyses of altered fetal lung development following single versus multiple courses of antenatal steroids. J Histochem Cytochem 2005;53:1459-1469.
30. Sunday ME, Kaplan LM, Motoyama E, Chin WW, Spindel ER. Biology of disease: gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease. Lab Invest 1988;59:5-24.
31. Mantey SA, Coy DH, Pradhan TK, Igarashi H, Rizo IM, Shen L, Hou W, Hocart SJ, Jensen RT. Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3. J Biol Chem 2001;276:9219-9229. Epub 2000 Dec 8.
32. Massaro GD, Massaro D. Formation of alveoli in rats: postnatal effect of prenatal dexamethasone. Am J Physiol 1992;263:L37-L41. [Published erratum appears in Am J Physiol 1992;263.]
33. Sunday ME. Bioactive peptides and lung development. In: Gaultier C, Bourbon JR, Post M, editors. Lung development, 1st ed. New York, Oxford: Oxford University Press; 1999. pp. 304-326.
34. Nakagawa T, Hocart SJ, Schumann M, Tapia JA, Mantey SA, Coy DH, Tokita K, Katsuno T, Jensen RT. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP). Biochem Pharmacol 2005;69:579-593. Epub 2004 Dec 23.
35. Tokita K, Hocart SJ, Coy DH, Jensen RT.Molecular basis of the selectivity of gastrin-releasing peptide receptor for gastrin-releasing peptide. Mol Pharmacol 2002;61:1435-1443.
36. Fathi Z, Benya RV, Shapira H, Jensen RT, Battey JF. The fifth transmembrane segment of the neuromedin B receptor is critical for high affinity neuromedin B binding. J Biol Chem 1993;268:14622-14626.
37. King KA, Hua J, Torday JS, Drazen JM, Graham SA, Shipp MA, Sunday ME. CD10/neutral endopeptidase regulates fetal lung growth and maturation in utero by potentiating endogenous bombesin-like peptides. J Clin Invest 1993;91:1969-1973.
38. Aguayo SM, Kane MA, King TE, Schwarz MI, Grauer L, Miller YE. Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic cigarette smokers. J Clin Invest 1989;84:1105-1113.
39. Nagalla SR, Barry BJ, Spindel ER. Cloning of complementary DNAs encoding the amphibian bombesin-like peptides Phe8 and Leu8 phyllolitorin from Phyllomedusa sauvagei: potential role of U to C RNA editing in generating neuropeptide diversity. Mol Endocrinol 1994;8:943-951.
40. Farstad T, Bratlid D. Incidence and prediction of bronchopulmonary dysplasia in a cohort of premature infants. Acta Paediatr 1994;83:19-24.
41. Parker RA, Lindstrom DP, Cotton RB. Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia. Semin Perinatol 1996;20:206-209.
42. Aguayo S, King T, Kane M, Sherritt K, Silvers W, Nett L, Petty T, Miller Y. Urinary levels of bombesin-like peptides in asymptomatic cigarette smokers: a potential risk marker for smoking-related diseases. Cancer Res 1992;52(Suppl. 9):2727s-2731s.
43. Aguayo SM. Determinants of susceptibility to cigarette smoke. Am J Respir Crit Care Med 1994;149:1692-1698.
44. Chang L, Subramaniam M, Yoder BA, Day BJ, Coalson JJ, Sunday M, Crapo JD. A catalytic antioxidant attenuates alveolar structural remodeling in bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 2003;167:57-64.
45. Dal-Pizzol F, Di Leone LP, Ritter C, Martins MR, Reinke A, Pens Gelain D, Zanotto-Filho A, de Souza LF, Andrades M, Barbeiro DF, et al. Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsis. Am J Respir Crit Care Med 2006;173:84-90. Epub 2005 Sep 28.